trastuzumab
roche
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'breast']
 phase 2, single-arm multicenter trial #esmo2022 anthracycline-based chemotherapy and #trastuzumab as neoadjuvant treatment for high-risk her2-positive #breastcancer 
#TumoriJournal is an international peer-reviewed journal focused on cancer research and clinical practice owned by @IstTumori Milan, IT